1. Home
  2. AYTU vs ELSE Comparison

AYTU vs ELSE Comparison

Compare AYTU & ELSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • ELSE
  • Stock Information
  • Founded
  • AYTU N/A
  • ELSE 1968
  • Country
  • AYTU United States
  • ELSE United States
  • Employees
  • AYTU N/A
  • ELSE N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • ELSE Industrial Machinery/Components
  • Sector
  • AYTU Health Care
  • ELSE Industrials
  • Exchange
  • AYTU Nasdaq
  • ELSE Nasdaq
  • Market Cap
  • AYTU 15.0M
  • ELSE 13.2M
  • IPO Year
  • AYTU N/A
  • ELSE N/A
  • Fundamental
  • Price
  • AYTU $2.26
  • ELSE $3.92
  • Analyst Decision
  • AYTU
  • ELSE
  • Analyst Count
  • AYTU 0
  • ELSE 0
  • Target Price
  • AYTU N/A
  • ELSE N/A
  • AVG Volume (30 Days)
  • AYTU 32.2K
  • ELSE 3.4K
  • Earning Date
  • AYTU 11-12-2024
  • ELSE 11-12-2024
  • Dividend Yield
  • AYTU N/A
  • ELSE N/A
  • EPS Growth
  • AYTU N/A
  • ELSE N/A
  • EPS
  • AYTU N/A
  • ELSE 0.06
  • Revenue
  • AYTU $81,002,000.00
  • ELSE $8,834,000.00
  • Revenue This Year
  • AYTU N/A
  • ELSE N/A
  • Revenue Next Year
  • AYTU N/A
  • ELSE N/A
  • P/E Ratio
  • AYTU N/A
  • ELSE $62.85
  • Revenue Growth
  • AYTU N/A
  • ELSE 3.78
  • 52 Week Low
  • AYTU $2.11
  • ELSE $3.65
  • 52 Week High
  • AYTU $3.50
  • ELSE $4.40
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 42.19
  • ELSE 48.99
  • Support Level
  • AYTU $2.11
  • ELSE $3.81
  • Resistance Level
  • AYTU $2.44
  • ELSE $4.14
  • Average True Range (ATR)
  • AYTU 0.13
  • ELSE 0.07
  • MACD
  • AYTU -0.02
  • ELSE -0.01
  • Stochastic Oscillator
  • AYTU 20.27
  • ELSE 32.61

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

About ELSE Electro-Sensors Inc.

Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.

Share on Social Networks: